Considerations in prophylaxis for tumor-associated epilepsy: Prevention of status epilepticus and tolerability of newer generation AEDs

Clinical Neurology and Neurosurgery

Volumn 115, Issue 11, 2013, Pages 2365-2369

  Wychowski, Thomas ^a   Wang, Hongyue ^b   Buniak, Liana ^a   Henry, J Craig ^a   Mohile, Nimish ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Anticonvulsants; Brain tumor; Epilepsy; Glioblastoma; Seizure

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; OXCARBAZEPINE; PHENYTOIN; VALPROIC ACID; ZONISAMIDE;

ADULT; ARTICLE; ATAXIA; CANCER DIAGNOSIS; CANCER PATIENT; CONFUSION; DEMOGRAPHY; DEPRESSION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPTIC STATE; FATIGUE; FEMALE; FOLLOW UP; GAIT DISORDER; GAIT INSTABILITY; GLIOBLASTOMA; HEADACHE; HUMAN; HUMAN TISSUE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PERIOPERATIVE PERIOD; RASH; RETROSPECTIVE STUDY; RISK FACTOR; SEIZURE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TOXIC EPIDERMAL NECROLYSIS;

ANTICONVULSANTS; BRAIN TUMOR; EPILEPSY; GLIOBLASTOMA; SEIZURE;

AGED; AGED, 80 AND OVER; ANTICONVULSANTS; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENYTOIN; PIRACETAM; RETROSPECTIVE STUDIES; RISK FACTORS; SEIZURES; STATUS EPILEPTICUS; TREATMENT OUTCOME;

EID: 84886954061     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2013.08.023     Document Type: Article

References (12)

1. T.A. Milligan, S. Hurwitz, and E.B. Bromfield Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery Neurology 71 2008 665 669
2. L.G. Kim, T.L. Johnson, A.G. Marson, D.W. Chadwick, and MRC MESS Study group Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial Lancet Neurol 5 2006 317 322
3. M.J. Glantz, B.F. Cole, P.A. Forsyth, L.D. Recht, P.Y. Wen, and M.C. Chamberlain Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 54 2000 1886 1893
4. A. Rosati, A. Tomassini, B. Pollo, C. Ambrosi, A. Schwarz, and A. Padovani Epilepsy in cerebral glioma: timing of appearance and histological correlations J Neurooncol 93 2009 395 400
5. P.L. Moots, and R.J. Maciunas The course of seizure disorders in patients with malignant gliomas Arch Neurol 52 1995 717 724
6. J.I. Sirven, D.M. Wingerchuk, J.F. Drazkowski, M.K. Lyons, and R.S. Zimmerman Seizure prophylaxis in patients with brain tumors: a metaanalysis Mayo Clin Proc 79 2004 1489 1494
7. S. Lwu, M.G. Hamilton, P.A. Forsyth, J.G. Cairncross, and I.F. Parney Use of peri-operative anti-epileptic drugs in patients with newly diagnosed high grade malignant glioma: a single center experience J Neurooncol 96 2010 403 408
8. K.L. Chaichana, S.L. Parker, A. Olivi, and A. Quiñones-Hinojosa Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. Clinical article J Neurosurg 111 2009 282 292
9. E.F. Chang, M.B. Potts, G.E. Keles, K.R. Lamborn, S.M. Chang, and N.M. Barbaro Seizure characteristics and control following resection in 332 patients with low-grade gliomas J Neurosurg 108 2008 227 235
10. S.C. Buckingham, S.L. Campbell, B.R. Haas, V. Montana, S. Robel, and T. Ogunrinu Glutamate release by primary brain tumors induces epileptic activity Nat Med 17 2011 1269 1274
11. R. Sutter, S. Marsch, P. Fuhr, and S. Ruegg Mortality and recovery from refractory status epilepticus in the intensive care unit: a 7-year observational study Epilepsia 54 3 2013 502 511
12. J.Y. Delattre, B. Safai, and J.B. Posner Erythma multiforme and Stevens-Johnson in patients receiving cranial irradiation and phenytoin Neurology 38 2 1988 194 198